Both in Surgical Instruments
Xtant Medical Holdings vs Nephros
Over the past year XTNT returned −65.5% and NEPH returned −38.5%; their daily moves had a correlation of 0.05.
XTNT −65.5% NEPH −38.5%Growth of $1, one year, split-adjusted
| Metric | XTNT | NEPH |
|---|---|---|
| Price | $0.2799 | $3.30 |
| Market cap | $39.3M | $35.9M |
| Today | −0.11% | +4.10% |
| 1 month | −17.9% | −10.1% |
| 6 months | −50.0% | +7.5% |
| Year to date | −64.3% | −32.4% |
| 1 year | −69.6% | −41.2% |
| Revenue growth (YoY) | −35.0% | +36.2% |
| Gross margin | 57.9% | 66.9% |
| Net margin | −40.9% | 19.9% |
| P/E (TTM) | — | 20.7× |
| Price / sales | 0.4× | 1.7× |
| Net cash | -$13.2M | $4.7M |
| Dividend yield | — | — |
| Volatility (60d) | 95.6% | 73.6% |
| Short % of float | 0.6% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).